Virgin Group and Bain Capital form Virgin Cruises

Richard Branson’s investment firm Virgin Group and  Bain Capital have partnered up to launch Virgin Cruises, a new cruise line business. No financial terms were disclosed. Also, Tom McAlpin will lead as CEO. Recently, McAlpin worked at The World, Residences at Sea where he served as president and CEO. Virgin Cruises is headquartered in the Miami/Fort Lauderdale area.


Bain, Apax join bid battle for Portugal Telecom-Reuters

Private equity firms Bain Capital and Apax Partners have launched a bid worth 7.075 billion euros ($8.8 billion) to buy the Portuguese operating business of Portugal Telecom from Brazil’s Oi (OIBR3.SA), rivalling an offer from European telecoms group Altice (ATCE.AS), Reuters reported.


Worldpay to acquire PE-owned SecureNet

Worldpay, which is backed by Advent International and Bain Capital, has agreed to buy SecureNet. No financial terms were disclosed. The deal is expected to be completed in December 2014. William Blair was financial advisor to SecureNet and its owner Sterling Partners on the transaction. Based in Austin, Texas, SecureNet is a payment solutions provider.


Bain Capital buys stake in TOMS

Bain Capital has acquired a 50 percent stake in TOMS. No financial terms were disclosed. As a result of the transaction, TOMS founder Blake Mycoskie will have a 50 percent ownership of the company. TOMS is a “one for one” shoe, eyewear and coffee company.


Second Opinion

In Second Opinion, Computer Sciences is interested in doing an LBO, Shyp is launching in NYC, Ripplewood Holdings stopped being a PE firm a while ago and who will be the next mayor of London.


Carlyle LPs to share in collusion suit settlement costs: Buyouts

The Carlyle Group’s $115 million settlement of a lawsuit that alleged it colluded with other buyout shops to depress deal prices will be paid through a combination of Carlyle Partners IV fund capital, insurance, balance sheet capital, and contributions from some employees of the firm.


Flex Pharma raises $40 mln from big investor group

Flex Pharma, a biopharmaceutical company focused on treatments for neuromuscular disorders, has raised $40 million from an investor group. Investors include Longwood Fund, Bessemer Venture Partners, EcoR1 Capital, Jennison Associates, Lightstone Ventures, Alexandria Equities, CD-Venture, Bindley Capital Partners, City Hill Ventures and several individuals including Steve Pagliuca, managing director at Bain Capital.

PE HUB Community

Join the 12514 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget